Review · not a partner · checked August 2026
$164/mo
Month to month, no prepay. Read off their site August 2026.
$164 is the cheapest 4-week supply of a compounded GLP-1, not a calendar month, and the visit that writes the prescription is billed separately at $250 if you pay cash.
Midi Health is a women's health practice that treats perimenopause and menopause, and weight is one of the things it treats. That framing matters to the price: you're booking a clinician visit, not subscribing to a GLP-1.
It is also the only company on this roster that is in-network with insurance, and the only one that publishes a complete dose table instead of a starting price. Thirty-two rows, four formats, every dose priced. Midi says twice, in its own words, that there are no membership fees, and nothing we read contradicts that.
| Plan | Per month | Charged today |
|---|---|---|
| Sublingual GLP-1, 0.075 mg · advertised | $164 | $164 |
| Injectable GLP-1, 0.1-0.5 mg | $165.90 | $165.90 |
| Sublingual GLP-1/GIP, 1 mg | $209 | $209 |
| Injectable GLP-1/GIP, 1.25 mg | $210 | $210 |
| Injectable GLP-1, 2.5 mg | $355 | $355 |
| Injectable GLP-1/GIP, 15 mg | $434 | $434 |
| Sublingual GLP-1/GIP, 7 mg | $460 | $460 |
Every figure on Midi's GLP-1 pricing page is headed "4-week supply", not a month, and the page prints a full dose table rather than a starting price. Midi never names the molecule, calling its products Compounded GLP-1 and Dual-Action GLP-1/GIP, so we do not name one either. Shipping and supplies are included. The rungs above are the entry and top prices of each of the four formats; the published table has 32 rows.
The advertised number is $164, and Midi is careful about what it buys: "Midi Compounded GLP-1 ** & GLP-1/GIP: Starts at $164 per 4-week supply, depending on medication, format, and dose." Four weeks is not a month. Thirteen supplies fill a 52-week year, so $164 a supply is $2,132 a year, or about $178 a calendar month. That is the honest comparison figure against a company that bills you twelve times.
The $164 is the cheapest rung of the cheapest format, sublingual GLP-1 at 0.075 mg. The cheapest injection is $165.90. From there it climbs hard: injectable GLP-1 is $270.90 at 0.75 mg and $355 at 2.5 mg, and the dual-action sublingual runs to $460 at 7 mg. Shipping and supplies are in every one of those prices.
Then the visit, which is the part the medication table does not cover. Insurance covers it for qualifying patients, and Midi is in-network with most major PPO plans. Self-pay is $250 for the 30-minute first visit and $150 for each 15-minute follow-up. So a cash-paying reader's first four weeks are $414, not $164. Midi is out of network with Medicare and says it can't accept Medicaid or Medi-Cal patients at this time.
The full breakdown — what is included, what is extra, and what happens at higher doses — is on the Midi Health cost page.
Anyone comparing $164 against another company's monthly price. It buys four weeks, and a year needs thirteen of them, so the like-for-like number is about $178.
Anyone paying cash who budgets only for medication. The first visit is $250 and follow-ups are $150; that's the part insurance is meant to carry here, and without insurance it is most of your first bill.
Anyone on Medicare or Medicaid. Midi is out of network with Medicare, welcomes Medicare beneficiaries only as self-pay patients who cannot submit claims, and says it can't accept Medicaid or Medi-Cal at this time.
Men. Midi treats women's health, and the whole service is built for that.
| Prescriber licensed in your state | Not stated |
| Pharmacy named | Precision Compounding Pharmacy, named in the terms; the GLP-1 pricing page adds that its partner compounding pharmacies are licensed and 503A-accredited |
| What you get | Compounded GLP-1 and dual-action GLP-1/GIP as injection or sublingual, plus brand-name GLP-1s sent to a pharmacy of your choice |
| Overseas fulfillment | Not stated |
| Support hours | Support Hours: M-F 9am - 5pm ET, published in the terms, with a phone line on 1-888-731-8994 |
These are the checks this site applies to every company — how we review. Not stated means we could not find it on their site, which is a finding about the site, not about the company.
Prices read 2026-08-31 on joinmidi.com. The headline is on https://joinmidi.com/weight-management, verbatim: "Midi Compounded GLP-1 ** & GLP-1/GIP: Starts at $164 per 4-week supply, depending on medication, format, and dose. Price includes shipping and supplies, and orders ship discreetly." The full dose table is on https://joinmidi.com/glp1-pricing, headed "GLP-1 Injectable 4-week supply" and "GLP-1 Sublingual 4-week supply", where the cheapest sublingual rung is $164.00 and the cheapest injectable rung is $165.90.
Visit pricing read 2026-08-31 on https://joinmidi.com/pricing-insurance: "First Visit 30-minutes ... Insurance Covered Self-pay $250" and "Returning Visit 15-minutes ... Insurance Covered Self-pay $150", with "Medicare is out of network with Midi" and "We're not able to accept Medicaid or Medi-Cal patients at this time" in the same block.
The pharmacy and the support hours are both in the terms at https://joinmidi.com/legals/terms-and-conditions, read 2026-08-31: "Our Service provides access to prescription fulfillment services offered by the following pharmacies: Precision Compounding Pharmacy" and "Support Hours: M-F 9am - 5pm ET."
What we could not find: we read the weight-management page, the GLP-1 pricing page, the pricing and insurance page, the contact page and the terms in full on 2026-08-31, searching each for the words licensed, state, overseas and international. Nothing on those five pages states that a Midi clinician is licensed in the patient's own state, and nothing states where medication is compounded beyond naming Precision Compounding Pharmacy. The site does say Midi is available in all 50 states, which is a statement about availability rather than licensure. Both rows read Not stated for that reason.
Midi labels compounded products clearly and repeats the disclosure on both pricing surfaces: "Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are made available to patients."
Midi Health's record is one of the inputs to this piece, so a correction here moves its numbers too.
Words used above: Compounded, Membership, Overseas fulfillment. All of them are in the glossary.
Not a partner. This link goes to Midi Health and pays us nothing. Who pays us.
Every company we have reviewed is on the reviews index, and the reviews are written by Kevin Turner. Your privacy choices and the terms of use apply to this page.